Cargando…
12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort
BACKGROUND: Short-term antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown previously. The further development remains to be determined. METHODS: We prospectively followed 29 coronavirus disease 2019 cases, mean age 44 ± 13.2 years. Except for one partici...
Autores principales: | Deisenhammer, Florian, Bauer, Angelika, Kavelar, Chiara, Rudzki, Dagmar, Rössler, Annika, Kimpel, Janine, Borena, Wegene, Reindl, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609251/ https://www.ncbi.nlm.nih.gov/pubmed/34812944 http://dx.doi.org/10.1007/s00508-021-01985-x |
Ejemplares similares
-
6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort
por: Deisenhammer, Florian, et al.
Publicado: (2020) -
High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz
por: Harthaller, Teresa, et al.
Publicado: (2022) -
Seroprevalence of SARS-CoV-2 infection in the Tyrolean district of Schwaz at the time of the rapid mass vaccination in March 2021 following B.1.351-variant outbreak
por: Willeit, Peter, et al.
Publicado: (2022) -
Regimen of Coronavirus Disease 2019 Vaccination Influences Extent and Kinetics of Antibody Avidity
por: Rössler, Annika, et al.
Publicado: (2022) -
Reduced sensitivity of antibody tests after omicron infection
por: Rössler, Annika, et al.
Publicado: (2023)